255 related articles for article (PubMed ID: 19166716)
1. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
Querques G
Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
[No Abstract] [Full Text] [Related]
2. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
3. Vitreomacular traction in a case of exudative age-related macular degeneration resistant to anti-VEGF therapy.
Shah SU; Haller JA
Acta Ophthalmol; 2012 Nov; 90(7):e569-70. PubMed ID: 22429537
[No Abstract] [Full Text] [Related]
4. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
[TBL] [Abstract][Full Text] [Related]
5. Age-related macular degeneration.
Brucker AJ
Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
[TBL] [Abstract][Full Text] [Related]
6. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy in the anti-VEGF era.
Fine HF
Br J Ophthalmol; 2007 Jun; 91(6):707-8. PubMed ID: 17510474
[TBL] [Abstract][Full Text] [Related]
8. Systemic safety of bilateral intravitreal anti-vascular endothelial growth factor injections.
Freund KB; Vance SK
Retina; 2011 Jan; 31(1):1-3. PubMed ID: 21187729
[No Abstract] [Full Text] [Related]
9. Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
Ziemssen F; Heiduschka P; Schraermeyer U;
Retina; 2007 Oct; 27(8):1154-6; author reply 1156-8. PubMed ID: 18040264
[No Abstract] [Full Text] [Related]
10. Combination therapy for age-related macular degeneration.
Patel S
Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
[TBL] [Abstract][Full Text] [Related]
11. Vitreomacular traction and age-related macular degeneration.
Green-Simms AE; Bakri SJ
Semin Ophthalmol; 2011 May; 26(3):137-8. PubMed ID: 21609226
[TBL] [Abstract][Full Text] [Related]
12. Strategies for inhibiting vascular endothelial growth factor.
Kaiser PK
Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
[TBL] [Abstract][Full Text] [Related]
13. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
Busch T
Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
[TBL] [Abstract][Full Text] [Related]
14. Value-based medicine.
Kymes SM; Vollman D; Frick KD
Ophthalmology; 2008 Nov; 115(11):2099; author reply 2100. PubMed ID: 19068385
[No Abstract] [Full Text] [Related]
15. Pathology beyond neovascularization: new targets in age-related macular degeneration.
Heier JS
Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
[TBL] [Abstract][Full Text] [Related]
16. Combination angiostatic therapies: current status.
Peyman GA; Fiscella R; Conway M
Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
[TBL] [Abstract][Full Text] [Related]
17. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration.
Krebs I; Glittenberg C; Zeiler F; Binder S
Br J Ophthalmol; 2011 Oct; 95(10):1415-8. PubMed ID: 21270433
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting angiogenesis in retinoblastoma.
Apte RS; Harbour JW
Ophthalmic Res; 2007; 39(4):188-90. PubMed ID: 17556838
[No Abstract] [Full Text] [Related]
19. VEGF and age-related macular degeneration.
McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
[No Abstract] [Full Text] [Related]
20. Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis?
la Cour M
Acta Ophthalmol Scand; 2007 Feb; 85(1):2-4. PubMed ID: 17244202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
